Selected research
Market Structure
Global Medical Grade Bioactive Glass Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Grade Bioactive Glass market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Grade Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Grade Bioactive Glass include Zimmer Biomet Holdings, Inc., Stryker, SCHOTT, BonAlive Biomaterials, NovaBone, Prosidyan, Beijing Xinfuyisheng High Technology, Guangzhou Kejin Material Technology and Ugulin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Medical Grade Bioactive Glass output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Medical Grade Bioactive Glass by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Medical Grade Bioactive Glass market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Grade Bioactive Glass and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Grade Bioactive Glass sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Grade Bioactive Glass market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Grade Bioactive Glass Segment by Company
Zimmer Biomet Holdings, Inc.
Stryker
SCHOTT
BonAlive Biomaterials
NovaBone
Prosidyan
Beijing Xinfuyisheng High Technology
Guangzhou Kejin Material Technology
Ugulin
Kunshan Overseas Chinese Technology New Materials
Zhangjiagang Lanzhi Biotechnology
Synergy Biomedical
Noraker
Mo-Sci Corporation
Matexcel
Ferro
3M
Medical Grade Bioactive Glass Segment by Type
45S5
S53P4
Others
Medical Grade Bioactive Glass Segment by Application
Bone Materials
Dental Materials
Medical Grade Bioactive Glass Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Grade Bioactive Glass market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Grade Bioactive Glass and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Grade Bioactive Glass.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Grade Bioactive Glass market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Grade Bioactive Glass industry.
Chapter 3: Detailed analysis of Medical Grade Bioactive Glass market competition landscape. Including Medical Grade Bioactive Glass manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Medical Grade Bioactive Glass by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Medical Grade Bioactive Glass in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 45S5
- S53P4
- Others
Applications
- Bone Materials
- Dental Materials
Companies covered
- Zimmer Biomet Holdings, Inc.
- Stryker
- SCHOTT
- BonAlive Biomaterials
- NovaBone
- Prosidyan
- Beijing Xinfuyisheng High Technology
- Guangzhou Kejin Material Technology
- Ugulin
- Kunshan Overseas Chinese Technology New Materials
- Zhangjiagang Lanzhi Biotechnology
- Synergy Biomedical
- Noraker
- Mo-Sci Corporation
- Matexcel
- Ferro
- 3M
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Grade Bioactive Glass Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Medical Grade Bioactive Glass Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Medical Grade Bioactive Glass Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Medical Grade Bioactive Glass Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Medical Grade Bioactive Glass Market Dynamics
- 2.1 Medical Grade Bioactive Glass Industry Trends
- 2.2 Medical Grade Bioactive Glass Industry Drivers
- 2.3 Medical Grade Bioactive Glass Industry Opportunities and Challenges
- 2.4 Medical Grade Bioactive Glass Industry Restraints
3 Medical Grade Bioactive Glass Market by Manufacturers
- 3.1 Global Medical Grade Bioactive Glass Production Value by Manufacturers (2021-2026)
- 3.2 Global Medical Grade Bioactive Glass Production by Manufacturers (2021-2026)
- 3.3 Global Medical Grade Bioactive Glass Average Price by Manufacturers (2021-2026)
- 3.4 Global Medical Grade Bioactive Glass Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Grade Bioactive Glass Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Grade Bioactive Glass Manufacturers, Product Type & Application
- 3.7 Global Medical Grade Bioactive Glass Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Grade Bioactive Glass Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Grade Bioactive Glass Players Market Share by Production Value in 2025
- 3.8.3 2025 Medical Grade Bioactive Glass Tier 1, Tier 2, and Tier 3
4 Medical Grade Bioactive Glass Market by Type
- 4.1 Medical Grade Bioactive Glass Type Introduction
- 4.1.1 45S5
- 4.1.2 S53P4
- 4.1.3 Others
- 4.2 Global Medical Grade Bioactive Glass Production by Type
- 4.2.1 Global Medical Grade Bioactive Glass Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Grade Bioactive Glass Production by Type (2021-2032)
- 4.2.3 Global Medical Grade Bioactive Glass Production Market Share by Type (2021-2032)
- 4.3 Global Medical Grade Bioactive Glass Production Value by Type
- 4.3.1 Global Medical Grade Bioactive Glass Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Grade Bioactive Glass Production Value by Type (2021-2032)
- 4.3.3 Global Medical Grade Bioactive Glass Production Value Market Share by Type (2021-2032)
5 Medical Grade Bioactive Glass Market by Application
- 5.1 Medical Grade Bioactive Glass Application Introduction
- 5.1.1 Bone Materials
- 5.1.2 Dental Materials
- 5.2 Global Medical Grade Bioactive Glass Production by Application
- 5.2.1 Global Medical Grade Bioactive Glass Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Grade Bioactive Glass Production by Application (2021-2032)
- 5.2.3 Global Medical Grade Bioactive Glass Production Market Share by Application (2021-2032)
- 5.3 Global Medical Grade Bioactive Glass Production Value by Application
- 5.3.1 Global Medical Grade Bioactive Glass Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Grade Bioactive Glass Production Value by Application (2021-2032)
- 5.3.3 Global Medical Grade Bioactive Glass Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Zimmer Biomet Holdings, Inc.
- 6.1.1 Zimmer Biomet Holdings, Inc. Company Information
- 6.1.2 Zimmer Biomet Holdings, Inc. Business Overview
- 6.1.3 Zimmer Biomet Holdings, Inc. Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.1.4 Zimmer Biomet Holdings, Inc. Medical Grade Bioactive Glass Product Portfolio
- 6.1.5 Zimmer Biomet Holdings, Inc. Recent Developments
- 6.2 Stryker
- 6.2.1 Stryker Company Information
- 6.2.2 Stryker Business Overview
- 6.2.3 Stryker Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.2.4 Stryker Medical Grade Bioactive Glass Product Portfolio
- 6.2.5 Stryker Recent Developments
- 6.3 SCHOTT
- 6.3.1 SCHOTT Company Information
- 6.3.2 SCHOTT Business Overview
- 6.3.3 SCHOTT Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.3.4 SCHOTT Medical Grade Bioactive Glass Product Portfolio
- 6.3.5 SCHOTT Recent Developments
- 6.4 BonAlive Biomaterials
- 6.4.1 BonAlive Biomaterials Company Information
- 6.4.2 BonAlive Biomaterials Business Overview
- 6.4.3 BonAlive Biomaterials Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.4.4 BonAlive Biomaterials Medical Grade Bioactive Glass Product Portfolio
- 6.4.5 BonAlive Biomaterials Recent Developments
- 6.5 NovaBone
- 6.5.1 NovaBone Company Information
- 6.5.2 NovaBone Business Overview
- 6.5.3 NovaBone Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.5.4 NovaBone Medical Grade Bioactive Glass Product Portfolio
- 6.5.5 NovaBone Recent Developments
- 6.6 Prosidyan
- 6.6.1 Prosidyan Company Information
- 6.6.2 Prosidyan Business Overview
- 6.6.3 Prosidyan Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.6.4 Prosidyan Medical Grade Bioactive Glass Product Portfolio
- 6.6.5 Prosidyan Recent Developments
- 6.7 Beijing Xinfuyisheng High Technology
- 6.7.1 Beijing Xinfuyisheng High Technology Company Information
- 6.7.2 Beijing Xinfuyisheng High Technology Business Overview
- 6.7.3 Beijing Xinfuyisheng High Technology Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.7.4 Beijing Xinfuyisheng High Technology Medical Grade Bioactive Glass Product Portfolio
- 6.7.5 Beijing Xinfuyisheng High Technology Recent Developments
- 6.8 Guangzhou Kejin Material Technology
- 6.8.1 Guangzhou Kejin Material Technology Company Information
- 6.8.2 Guangzhou Kejin Material Technology Business Overview
- 6.8.3 Guangzhou Kejin Material Technology Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.8.4 Guangzhou Kejin Material Technology Medical Grade Bioactive Glass Product Portfolio
- 6.8.5 Guangzhou Kejin Material Technology Recent Developments
- 6.9 Ugulin
- 6.9.1 Ugulin Company Information
- 6.9.2 Ugulin Business Overview
- 6.9.3 Ugulin Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.9.4 Ugulin Medical Grade Bioactive Glass Product Portfolio
- 6.9.5 Ugulin Recent Developments
- 6.10 Kunshan Overseas Chinese Technology New Materials
- 6.10.1 Kunshan Overseas Chinese Technology New Materials Company Information
- 6.10.2 Kunshan Overseas Chinese Technology New Materials Business Overview
- 6.10.3 Kunshan Overseas Chinese Technology New Materials Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.10.4 Kunshan Overseas Chinese Technology New Materials Medical Grade Bioactive Glass Product Portfolio
- 6.10.5 Kunshan Overseas Chinese Technology New Materials Recent Developments
- 6.11 Zhangjiagang Lanzhi Biotechnology
- 6.11.1 Zhangjiagang Lanzhi Biotechnology Company Information
- 6.11.2 Zhangjiagang Lanzhi Biotechnology Business Overview
- 6.11.3 Zhangjiagang Lanzhi Biotechnology Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.11.4 Zhangjiagang Lanzhi Biotechnology Medical Grade Bioactive Glass Product Portfolio
- 6.11.5 Zhangjiagang Lanzhi Biotechnology Recent Developments
- 6.12 Synergy Biomedical
- 6.12.1 Synergy Biomedical Company Information
- 6.12.2 Synergy Biomedical Business Overview
- 6.12.3 Synergy Biomedical Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.12.4 Synergy Biomedical Medical Grade Bioactive Glass Product Portfolio
- 6.12.5 Synergy Biomedical Recent Developments
- 6.13 Noraker
- 6.13.1 Noraker Company Information
- 6.13.2 Noraker Business Overview
- 6.13.3 Noraker Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.13.4 Noraker Medical Grade Bioactive Glass Product Portfolio
- 6.13.5 Noraker Recent Developments
- 6.14 Mo-Sci Corporation
- 6.14.1 Mo-Sci Corporation Company Information
- 6.14.2 Mo-Sci Corporation Business Overview
- 6.14.3 Mo-Sci Corporation Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.14.4 Mo-Sci Corporation Medical Grade Bioactive Glass Product Portfolio
- 6.14.5 Mo-Sci Corporation Recent Developments
- 6.15 Matexcel
- 6.15.1 Matexcel Company Information
- 6.15.2 Matexcel Business Overview
- 6.15.3 Matexcel Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.15.4 Matexcel Medical Grade Bioactive Glass Product Portfolio
- 6.15.5 Matexcel Recent Developments
- 6.16 Ferro
- 6.16.1 Ferro Company Information
- 6.16.2 Ferro Business Overview
- 6.16.3 Ferro Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.16.4 Ferro Medical Grade Bioactive Glass Product Portfolio
- 6.16.5 Ferro Recent Developments
- 6.17 3M
- 6.17.1 3M Company Information
- 6.17.2 3M Business Overview
- 6.17.3 3M Medical Grade Bioactive Glass Production, Value and Gross Margin (2021-2026)
- 6.17.4 3M Medical Grade Bioactive Glass Product Portfolio
- 6.17.5 3M Recent Developments
7 Global Medical Grade Bioactive Glass Production by Region
- 7.1 Global Medical Grade Bioactive Glass Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Medical Grade Bioactive Glass Production by Region (2021-2032)
- 7.2.1 Global Medical Grade Bioactive Glass Production by Region (2021-2026)
- 7.2.2 Global Medical Grade Bioactive Glass Production Forecast by Region (2027-2032)
- 7.3 Global Medical Grade Bioactive Glass Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Medical Grade Bioactive Glass Production Value by Region (2021-2032)
- 7.4.1 Global Medical Grade Bioactive Glass Production Value by Region (2021-2026)
- 7.4.2 Global Medical Grade Bioactive Glass Production Value by Region (2027-2032)
- 7.5 Global Medical Grade Bioactive Glass Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Medical Grade Bioactive Glass Production Value (2021-2032)
- 7.6.2 Europe Medical Grade Bioactive Glass Production Value (2021-2032)
- 7.6.3 Asia-Pacific Medical Grade Bioactive Glass Production Value (2021-2032)
- 7.6.4 South America Medical Grade Bioactive Glass Production Value (2021-2032)
- 7.6.5 Middle East & Africa Medical Grade Bioactive Glass Production Value (2021-2032)
8 Global Medical Grade Bioactive Glass Consumption by Region
- 8.1 Global Medical Grade Bioactive Glass Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Medical Grade Bioactive Glass Consumption by Region (2021-2032)
- 8.2.1 Global Medical Grade Bioactive Glass Consumption by Region (2021-2026)
- 8.2.2 Global Medical Grade Bioactive Glass Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Medical Grade Bioactive Glass Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Medical Grade Bioactive Glass Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Medical Grade Bioactive Glass Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Medical Grade Bioactive Glass Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Medical Grade Bioactive Glass Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Medical Grade Bioactive Glass Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Medical Grade Bioactive Glass Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Medical Grade Bioactive Glass Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Medical Grade Bioactive Glass Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Medical Grade Bioactive Glass Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Grade Bioactive Glass Value Chain Analysis
- 9.1.1 Medical Grade Bioactive Glass Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Grade Bioactive Glass Production Mode & Process
- 9.2 Medical Grade Bioactive Glass Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Grade Bioactive Glass Distributors
- 9.2.3 Medical Grade Bioactive Glass Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst